A

Alabama Neurology Associates | Birmingham, AL

Research site
(Unclaimed)
Location
3105 Independence Drive, Suite 105, Birmingham, Alabama, United States of America

Site insights

Top conditions

Top treatments

SAR441344
Frexalimab
Avonex
Riliprubart
Zocor

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work (MOBILIZE)

The purpose of the study is to evaluate efficacy of riliprubart compared to placebo in adult participants with CIDP whose disease is refractory to st...

Enrolling
Polyneuropathy, Inflammatory Demyelinating, Chronic
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Drug: Placebo
Drug: Riliprubart

The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatm...

Enrolling
Chronic Inflammatory Demyelinating Polyneuropathy
Drug: IVIg
Drug: riliprubart

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

Trial sponsors

Sanofi logo
Merck KGaA (EMD Serono) logo
I
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems